MARKET

IMNN

IMNN

Imunon Inc
NASDAQ
1.650
+0.070
+4.43%
After Hours: 1.580 -0.07 -4.24% 19:34 08/14 EDT
OPEN
1.580
PREV CLOSE
1.580
HIGH
1.670
LOW
1.570
VOLUME
56.77K
TURNOVER
--
52 WEEK HIGH
7.21
52 WEEK LOW
1.470
MARKET CAP
9.26M
P/E (TTM)
-0.3734
1D
5D
1M
3M
1Y
5Y
1D
Imunon: Buy Rating Reiterated as Phase 3 IMNN-001 Progress and Extended Cash Runway Support Unchanged $10 Price Target
TipRanks · 4d ago
Imunon (IMNN) Q2 2026 Earnings Call Transcript
NASDAQ · 4d ago
Imunon Adopts New Equity-Based Executive Compensation Program
TipRanks · 4d ago
IMUNON Advances OVATION 3 Trial Of IMNN-001; Enrollment Expected To Complete In 1H29
NASDAQ · 5d ago
Imunon GAAP EPS of -$0.54 beats by $0.50
Seeking Alpha · 5d ago
Imunon Q2 EPS $(0.54) Beats $(0.93) Estimate
Benzinga · 5d ago
Here are the major earnings before the open Tuesday
Seeking Alpha · 5d ago
Weekly Report: what happened at IMNN last week (0803-0807)?
Weekly Report · 6d ago
More
About IMNN
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases, constituting a differentiating approach from conventional therapies. The Company is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the gene-based delivery of cytokines and other therapeutic proteins in the treatment of solid tumors. The second modality, PlaCCine, is developed for the gene delivery of viral antigens that can elicit a strong immunological response. The Company’s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer that has completed Phase 2 development. IMNN-001 works by instructing the body to produce safe and durable levels of powerful cancer-fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site.

Webull offers Imunon Inc stock information, including NASDAQ: IMNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMNN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMNN stock methods without spending real money on the virtual paper trading platform.